These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32321978)

  • 1. Plasma Donors in the Southwestern United States Positively Contribute to the Diverse Therapeutic Antibody Profile of Immune Globulin Products.
    Ciencewicki JM; Schouest KR; Gierman TM; Vandeberg PJ; Gooch BD
    Sci Rep; 2020 Apr; 10(1):6850. PubMed ID: 32321978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term monitoring of virus antibody titers in human intravenous immunoglobulin lots derived from donors in Japan.
    Onodera H; Nakagawa R; Nakagawa H; Urayama T; Haino K; Yunoki M
    Transfusion; 2018 Nov; 58(11):2617-2626. PubMed ID: 30284288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to hepatitis A virus in immune serum globulin.
    Smallwood LA; Tabor E; Finlayson JS; Gerety RJ
    J Med Virol; 1981; 7(1):21-7. PubMed ID: 7241098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A virus antibodies in immunoglobulin preparations.
    Farcet MR; Planitzer CB; Stein O; Modrof J; Kreil TR
    J Allergy Clin Immunol; 2010 Jan; 125(1):198-202. PubMed ID: 19962745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
    Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in measles antibody titers in plasma donors and minimum antibody levels of immunoglobulin products for treatment of primary immunodeficiency.
    Simon TL; FitzGerald P; Kühne M; Farrar C; Knowles J; Bycholski K; Zenker O
    Transfusion; 2018 Dec; 58 Suppl 3():3065-3071. PubMed ID: 30536437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis.
    Lackner C; Karbiener M; Faltner L; Farcet MR; Kreil TR
    Immunol Res; 2022 Jun; 70(3):365-370. PubMed ID: 35266077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles-virus-neutralizing antibodies in intravenous immunoglobulins.
    Audet S; Virata-Theimer ML; Beeler JA; Scott DE; Frazier DJ; Mikolajczyk MG; Eller N; Chen FM; Yu MY
    J Infect Dis; 2006 Sep; 194(6):781-9. PubMed ID: 16941344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products.
    Lee S; Kim HW; Kim KH
    J Korean Med Sci; 2016 Dec; 31(12):1937-1942. PubMed ID: 27822932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
    Modrof J; Tille B; Farcet MR; McVey J; Schreiner JA; Borders CM; Gudino M; Fitzgerald P; Simon TL; Kreil TR
    J Infect Dis; 2017 Nov; 216(8):977-980. PubMed ID: 28968738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus.
    Falk JJ; Winkelmann M; Schrezenmeier H; Stöhr D; Sinzger C; Lotfi R
    Transfusion; 2017 Feb; 57(2):412-422. PubMed ID: 27861998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
    Wang X; Xu Y; Scott DE; Murata H; Struble EB
    Biologicals; 2017 Nov; 50():35-41. PubMed ID: 29029807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors.
    Roth NJ; Schäfer W; Alexander R; Elliott K; Elliott-Browne W; Knowles J; Wenzel JJ; Simon TL
    Transfusion; 2017 Dec; 57(12):2958-2964. PubMed ID: 28833188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement and assessment of cytomegalovirus of immunoglobulin (Ig) g titer in preparations.
    Shibaguchi H; Yamamoto T; Kuroki M; Futagami K
    Yakugaku Zasshi; 2010 Jul; 130(7):977-82. PubMed ID: 20606378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
    Wasserman RL; Greener BN; Mond J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1107-1119. PubMed ID: 29035131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.
    Yajima M; Shiraki A; Daikoku T; Oyama Y; Yoshida Y; Shiraki K
    J Infect Chemother; 2015 Jun; 21(6):427-33. PubMed ID: 25824903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation.
    Cortez K; Murphy BR; Almeida KN; Beeler J; Levandowski RA; Gill VJ; Childs RW; Barrett AJ; Smolskis M; Bennett JE
    J Infect Dis; 2002 Sep; 186(6):834-8. PubMed ID: 12198619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the results of two analytical methods for measuring measles virus neutralizing antibodies in source plasma and therapeutic immunoglobulin products.
    Hong J; Kim D; Won Y; Yoon J; Park KJ; Oh J; Kim CW
    Biologicals; 2019 May; 59():20-28. PubMed ID: 30992162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patients.
    Filipovich AH; Peltier MH; Bechtel MK; Dirksen CL; Strauss SA; Englund JA
    Blood; 1992 Nov; 80(10):2656-60. PubMed ID: 1330079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles virus neutralizing antibodies in immunoglobulin lots produced from plasma collected in Europe or the United States.
    Farcet MR; Karbiener M; Rabel PO; Schirmer A; Ilk R; Kreil TR
    Vaccine; 2019 May; 37(24):3151-3153. PubMed ID: 31060953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.